chr20-46174905-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_021248.3(CDH22):ā€‹c.2088G>Cā€‹(p.Glu696Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000921 in 1,411,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000040 ( 0 hom., cov: 31)
Exomes š‘“: 0.0000055 ( 0 hom. )

Consequence

CDH22
NM_021248.3 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.56
Variant links:
Genes affected
CDH22 (HGNC:13251): (cadherin 22) This gene is a member of the cadherin superfamily. The gene product is composed of five cadherin repeat domains and a cytoplasmic tail similar to the highly conserved cytoplasmic region of classical cadherins. Expressed predominantly in the brain, this putative calcium-dependent cell adhesion protein may play an important role in morphogenesis and tissue formation in neural and non-neural cells during development and maintenance of the brain and neuroendocrine organs. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0675067).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CDH22NM_021248.3 linkuse as main transcriptc.2088G>C p.Glu696Asp missense_variant 12/12 ENST00000537909.4
CDH22XM_011528994.3 linkuse as main transcriptc.2088G>C p.Glu696Asp missense_variant 12/12
CDH22XM_047440373.1 linkuse as main transcriptc.1848G>C p.Glu616Asp missense_variant 10/10
CDH22XM_024451966.2 linkuse as main transcriptc.1725G>C p.Glu575Asp missense_variant 12/12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CDH22ENST00000537909.4 linkuse as main transcriptc.2088G>C p.Glu696Asp missense_variant 12/122 NM_021248.3 P1

Frequencies

GnomAD3 genomes
AF:
0.0000404
AC:
6
AN:
148454
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000284
AC:
5
AN:
175976
Hom.:
0
AF XY:
0.0000201
AC XY:
2
AN XY:
99568
show subpopulations
Gnomad AFR exome
AF:
0.000460
Gnomad AMR exome
AF:
0.0000407
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000554
AC:
7
AN:
1263102
Hom.:
0
Cov.:
36
AF XY:
0.00000319
AC XY:
2
AN XY:
626378
show subpopulations
Gnomad4 AFR exome
AF:
0.000191
Gnomad4 AMR exome
AF:
0.0000308
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000202
GnomAD4 genome
AF:
0.0000404
AC:
6
AN:
148454
Hom.:
0
Cov.:
31
AF XY:
0.0000138
AC XY:
1
AN XY:
72382
show subpopulations
Gnomad4 AFR
AF:
0.000147
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000436
Hom.:
0
Bravo
AF:
0.0000529
ESP6500AA
AF:
0.000515
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000416
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 10, 2024The c.2088G>C (p.E696D) alteration is located in exon 11 (coding exon 11) of the CDH22 gene. This alteration results from a G to C substitution at nucleotide position 2088, causing the glutamic acid (E) at amino acid position 696 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.012
T;T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.19
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.72
.;T
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.068
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.65
N;N
MutationTaster
Benign
0.95
D;D
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
0.10
N;N
REVEL
Benign
0.079
Sift
Benign
0.27
T;T
Sift4G
Benign
0.35
T;T
Polyphen
0.046
B;B
Vest4
0.16
MutPred
0.42
Loss of sheet (P = 0.0054);Loss of sheet (P = 0.0054);
MVP
0.57
ClinPred
0.11
T
GERP RS
3.9
Varity_R
0.11
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374948412; hg19: chr20-44803544; API